Wells Fargo’s Lyell Immunopharma LYEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17.4K | Sell |
1,970
-2,853
| -59% | -$25.2K | ﹤0.01% | 5378 |
|
|
2025
Q1 | $51.9K | Buy |
4,823
+107
| +2% | +$1.15K | ﹤0.01% | 4933 |
|
|
2024
Q4 | $60.4K | Buy |
4,716
+1,027
| +28% | +$13.1K | ﹤0.01% | 4925 |
|
|
2024
Q3 | $102K | Buy |
3,689
+159
| +5% | +$4.39K | ﹤0.01% | 4620 |
|
|
2024
Q2 | $102K | Buy |
3,530
+468
| +15% | +$13.6K | ﹤0.01% | 4569 |
|
|
2024
Q1 | $137K | Buy |
3,062
+393
| +15% | +$17.5K | ﹤0.01% | 4341 |
|
|
2023
Q4 | $104K | Sell |
2,669
-3,334
| -56% | -$129K | ﹤0.01% | 4474 |
|
|
2023
Q3 | $176K | Sell |
6,003
-33
| -0.5% | -$970 | ﹤0.01% | 4127 |
|
|
2023
Q2 | $384K | Buy |
6,036
+296
| +5% | +$18.8K | ﹤0.01% | 3921 |
|
|
2023
Q1 | $271K | Buy |
+5,740
| New | +$271K | ﹤0.01% | 3997 |
|
|
2022
Q4 | – | Sell |
-78
| Closed | -$12K | – | 7262 |
|
|
2022
Q3 | $12K | Buy |
78
+18
| +30% | +$2.77K | ﹤0.01% | 5282 |
|
|
2022
Q2 | $8K | Sell |
60
-394
| -87% | -$52.5K | ﹤0.01% | 5547 |
|
|
2022
Q1 | $46K | Buy |
454
+452
| +22,600% | +$45.8K | ﹤0.01% | 5366 |
|
|
2021
Q4 | $0 | Sell |
2
-4
| -67% | – | ﹤0.01% | 6994 |
|
|
2021
Q3 | $2K | Buy |
+6
| New | +$2K | ﹤0.01% | 6244 |
|